SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-22-012267
Filing Date
2022-08-04
Accepted
2022-08-04 16:48:28
Documents
61
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q vygr-20220630x10q.htm   iXBRL 10-Q 2114621
2 EX-31.1 vygr-20220630xex31d1.htm EX-31.1 13687
3 EX-31.2 vygr-20220630xex31d2.htm EX-31.2 13750
4 EX-32.1 vygr-20220630xex32d1.htm EX-32.1 10707
5 GRAPHIC vygr-20220630x10q006.jpg GRAPHIC 116673
  Complete submission text file 0001558370-22-012267.txt   7266500

Data Files

Seq Description Document Type Size
6 EX-101.SCH vygr-20220630.xsd EX-101.SCH 47933
7 EX-101.CAL vygr-20220630_cal.xml EX-101.CAL 43510
8 EX-101.DEF vygr-20220630_def.xml EX-101.DEF 196009
9 EX-101.LAB vygr-20220630_lab.xml EX-101.LAB 387114
10 EX-101.PRE vygr-20220630_pre.xml EX-101.PRE 310341
55 EXTRACTED XBRL INSTANCE DOCUMENT vygr-20220630x10q_htm.xml XML 1088210
Mailing Address 64 SIDNEY STREET CAMBRIDGE MA 02139
Business Address 64 SIDNEY STREET CAMBRIDGE MA 02139 857-259-5340
Voyager Therapeutics, Inc. (Filer) CIK: 0001640266 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37625 | Film No.: 221137421
SIC: 2836 Biological Products, (No Diagnostic Substances)